Jivan Sambridhi Pharmaceuticals Private Limited
About Jivan Sambridhi Pharmaceuticals Private Limited
Data last updated:
Jivan Sambridhi Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 September 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U33110WB2011PTC167834. Its GSTIN is 19AACCJ7187J1ZZ (West Bengal).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹4.04 Lakh. It is led by directors including Mohammad Faruk Uddin and Amit Ray.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 166 Jodhpur Park Ground Floor, Kolkata, West Bengal, India – 700068.
As per the financials filed for FY 2025, the company reported a revenue of ₹47.25 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.34 Lakh (net margin 2.8%) and EBITDA of ₹3.61 Lakh (EBITDA margin 7.6%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Jivan Sambridhi Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address is in the company report.
- Email
- Registered Address166 Jodhpur Park Ground Floor, Kolkata, West Bengal, India – 700068
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Jivan Sambridhi Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Jivan Sambridhi Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Jivan Sambridhi Pharmaceuticals Private Limited, buy the company report.
Financials of Jivan Sambridhi Pharmaceuticals Private Limited
FY 2025 filings availableJivan Sambridhi Pharmaceuticals Private Limited reported revenue of ₹47.25 Lakh (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 2% growth in the latest year. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.61 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.6% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jivan Sambridhi Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jivan Sambridhi Pharmaceuticals Private Limited
Jivan Sambridhi Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Faruk Uddin Also directs: Griebs Organics Private Limited, Pancharhat Farmers Producer Company Limited, Griebs Music Private Limited and 5 more | Director | 28 Dec 2018 | 7 Years 10 Months | Current |
| Amit Ray | Director | 22 Feb 2020 | 6 Years 8 Months | Current |
| Mohammed Amirul Islam | Director | 02 May 2024 | 2 Years 6 Months | Current |
Auditor
Jivan Sambridhi Pharmaceuticals Private Limited is audited by SANJIVA & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJIVA & ASSOCIATES | FY 2019 | 323317E |
Shareholding
The shareholding of Jivan Sambridhi Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Jivan Sambridhi Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Feb 2024 | 100871805 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Jivan Sambridhi Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jivan Sambridhi Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jivan Sambridhi Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AACCJ7187J1ZZ | West Bengal | Active | 26 Oct 2018 |
To see the full GST registrations and return filing status of Jivan Sambridhi Pharmaceuticals Private Limited, buy the company report.
Recent activity
Jivan Sambridhi Pharmaceuticals Private Limited has 8 board changes on record since 2017: 3 appointments and 5 cessations. The latest: Mohammed Amirul Islam was appointed as Director on 02 May 2024.
Frequently asked questions
Jivan Sambridhi Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 September 2011 (15+ years old) and is registered under CIN U33110WB2011PTC167834.
Jivan Sambridhi Pharmaceuticals has 3 current directors:
- Mohammad Faruk Uddin - Director
- Amit Ray - Director
- Mohammed Amirul Islam - Director
The latest financial statements of Jivan Sambridhi Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Jivan Sambridhi Pharmaceuticals is 19AACCJ7187J1ZZ, registered in West Bengal.
The CIN (Corporate Identification Number) of Jivan Sambridhi Pharmaceuticals is U33110WB2011PTC167834. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jivan Sambridhi Pharmaceuticals was incorporated on 20 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Kolkata.
Mohammed Amirul Islam was appointed as Director on 02 May 2024. Kiran Ramakant Bansode ceased to be Director on 16 Oct 2020. Amit Ray was appointed as Director on 22 Feb 2020. Jivan Sambridhi Pharmaceuticals has 8 board changes on record in total.
The registered office of Jivan Sambridhi Pharmaceuticals is at 166 Jodhpur Park Ground Floor, Kolkata, West Bengal, India – 700068.
Jivan Sambridhi Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Jivan Sambridhi Pharmaceuticals has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
